Human herpesvirus 6B induces phosphorylation of p53 in its regulatory domain by a CK2- and p38-independent pathway

Journal of General Virology

Volumn 89, Issue 1, 2008, Pages 87-96

  Oster B ^a,b   Bundgaard, B ^a   Hupp, T R ^b   Hollsberg P ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

5,6 DICHLOROBENZIMIDAZOLE RIBOSIDE; CASEIN KINASE II; CASEIN KINASE IIBETA; CYCLIN DEPENDENT KINASE 9; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; P38ALPHA PROTEIN; PHOSPHOTRANSFERASE; PROTEIN KINASE INHIBITOR; PROTEIN KINASE R; PROTEIN P53; SERINE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ARTICLE; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME ACTIVITY; ENZYME ASSAY; HERPES VIRUS INFECTION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6B; IN VITRO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS REPLICATION;

CASEIN KINASE II; CELL LINE; EPITHELIAL CELLS; HERPESVIRUS 6, HUMAN; HUMANS; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RNA, SMALL INTERFERING; SERINE; TUMOR SUPPRESSOR PROTEIN P53;

HUMAN HERPESVIRUS 6; HUMAN HERPESVIRUS 6B; MURINAE;

EID: 38349056672     PISSN: 00221317     EISSN: None     Source Type: Journal    
DOI: 10.1099/vir.0.83136-0     Document Type: Article

References (55)

1. Adamson, A. L., Darr, D., Holley-Guthrie, E., Johnson, R. A., Mauser, A., Swenson, J. & Kenney, S. (2000). Epstein-Barr virus immediate-early proteins BZLF1 and BRLF1 activate the ATF2 transcription factor by increasing the levels of phosphorylated p38 and c-Jun N-terminal kinases. J Virol 74, 1224-1233.
2. Blaydes, J. P., Craig, A. L., Wallace, M., Ball, H. M., Traynor, N. J., Gibbs, N. K. & Hupp, T. R. (2000a). Synergistic activation of p53-dependent transcription by two cooperating damage recognition pathways. Oncogene 19, 3829-3839.
3. Blaydes, J. P., Vojtesek, B., Bloomberg, G. B. & Hupp, T. R. (2000b). The development and use of phospho-specific antibodies to study protein phosphorylation. Methods Mol Biol 99, 177-189.
4. Bonin, L. R. & McDougall, J. K. (1997). Human cytomegalovirus IE2 86-kilodalton protein binds p53 but does not abrogate G1 checkpoint function. J Virol 71, 5861-5870.
5. Boutell, C. & Everett, R. D. (2004). Herpes simplex virus type 1 infection induces the stabilization of p53 in a USP7- and ATM-independent manner. J Virol 78, 8068-8077.
6. Bradham, C. & McClay, D. R. (2006). p38 MAPK in development and cancer. Cell Cycle 5, 824-828.
7. Braun, D. K., Dominguez, G. & Pellett, P. E. (1997). Human herpesvirus 6. Clin Microbiol Rev 10, 521-567.
8. Bruins, W., Zwart, E., Attardi, L. D., Iwakuma, T., Hoogervorst, E. M., Beems, R. B., Miranda, B., van Oostrom, C. T., van den Berg, J. & other authors (2004). Increased sensitivity to UV radiation in mice with a p53 point mutation at Ser389. Mol Cell Biol 24, 8884-8894.
9. Buchou, T., Vernet, M., Blond, O., Jensen, H. H., Pointu, H., Olsen, B. B., Cochet, C., Issinger, O. G. & Boldyreff, B. (2003). Disruption of the regulatory β subunit of protein kinase CK2 in mice leads to a cell-autonomous defect and early embryonic lethality. Mol Cell Biol 23, 908-915.
10. Bulavin, D. V., Saito, S., Hollander, M. C., Sakaguchi, K., Anderson, C. W., Appella, E. & Fornace, A. J., Jr (1999). Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation. EMBO J 18, 6845-6854.
11. Castillo, J. P., Frame, F. M., Rogoff, H. A., Pickering, M. T., Yurochko, A. D. & Kowalik, T. F. (2005). Human cytomegalovirus IE1-72 activates ataxia telangiectasia mutated kinase and a p53/ p21-mediated growth arrest response. J Virol 79, 11467-11475.
12. Claudio, P. P., Cui, J., Ghafouri, M., Mariano, C., White, M. K., Safak, M., Sheffield, J. B., Giordano, A., Khalili, K. & other authors (2006). Cdk9 phosphorylates p53 on serine 392 independently of CKII. J Cell Physiol 208, 602-612.
13. Collot-Teixeira, S., Bass, J., Denis, F. & Ranger-Rogez, S. (2004). Human tumor suppressor p53 and DNA viruses. Rev Med Virol 14, 301-319.
14. Cuddihy, A. R., Wong, A. H., Tam, N. W., Li, S. & Koromilas, A. E. (1999). The double-stranded RNA activated protein kinase PKR physically associates with the tumor suppressor p53 protein and phosphorylates human p53 on serine 392 in vitro. Oncogene 18, 2690-2702.
15. 2 phase of the cell cycle. FEBS Lett 560, 25-29.
16. de Falco, G. & Giordano, A. (1998). CDK9 (PITALRE): a multi-functional cdc2-related kinase. J Cell Physiol 177, 501-506.
17. Dudley, D. T., Pang, L., Decker, S. J., Bridges, A. J. & Saltiel, A. R. (1995). A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proc Natl Acad Sci U S A 92, 7686-7689.
18. 2/M in Saccharomyces cerevisiae. J Biol Chem 270, 25905-25914.
19. Hoogervorst, E. M., Bruins, W., Zwart, E., van Oostrom, C. T., van den Aardweg, G. J., Beems, R. B., van den Berg, J., Jacks, T., van Steeg, H. & de Vries, A. (2005). Lack of p53 Ser389 phosphorylation predisposes mice to develop 2-acetylaminofluorene-induced bladder tumors but not ionizing radiation-induced lymphomas. Cancer Res 65, 3610-3616.
20. Huang, C., Ma, W. Y., Maxiner, A., Sun, Y. & Dong, Z. (1999). p38 kinase mediates UV-induced phosphorylation of p53 protein at serine 389. J Biol Chem 274, 12229-12235.
21. Hupp, T. R. & Lane, D. P. (1994). Allosteric activation of latent p53 tetramers. Curr Biol 4, 865-875.
22. Hupp, T. R., Meek, D. W., Midgley, C. A. & Lane, D. P. (1992). Regulation of the specific DNA binding function of p53. Cell 71, 875-886.
23. Hupp, T. R., Lane, D. P. & Ball, K. L. (2000). Strategies for manipulating the p53 pathway in the treatment of human cancer. Biochem J 352, 1-17.
24. Jin, S. & Levine, A. J. (2001). The p53 functional circuit. J Cell Sci 114, 4139-4140.
25. Kashanchi, F., Araujo, J., Doniger, J., Muralidhar, S., Hoch, R., Khleif, S., Mendelson, E., Thompson, J., Azumi, N. & other authors (1997). Human herpesvirus 6 (HHV-6) ORT-1 transactivating gene exhibits malignant transforming activity and its protein binds to p53. Oncogene 14, 359-367.
26. Keller, D., Zeng, X., Li, X., Kapoor, M., lordanov, M. S., Taya, Y., Lozano, G., Magun, B. & Lu, H. (1999). The p38MAPK inhibitor SB203580 alleviates ultraviolet- induced phosphorylation at serine 389 but not serine 15 and activation of p53. Biochem Biophys Res Commun 261, 464-471.
27. Keller, D. M., Zeng, X., Wang, Y., Zhang, Q. H., Kapoor, M., Shu, H., Goodman, R., Lozano, G., Zhao, Y. & Lu, H. (2001). A DNA damage-induced p53 serine 392 kinase complex contains CK2, hSpt16, and SSRP1. Mol Cell 7, 283-292.
28. Kudoh, A., Fujita, M., Zhang, L., Shirata, N., Daikoku, T., Sugaya, Y., Isomura, H., Nishiyama, Y. & Tsurumi, T. (2005). Epstein-Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J Biol Chem 280, 8156-8163.
29. Langland, J. O., Cameron, J. M., Heck, M. C., Jancovich, J. K. & Jacobs, B. L. (2006). Inhibition of PKR by RNA and DNA viruses. Virus Res 119, 100-110.
30. Levine, A. J. (1997). p53, the cellular gatekeeper for growth and division. Cell 88, 323-331.
31. Liang, S. H., Hong, D. & Clarke, M. F. (1998). Cooperation of a single lysine mutation and a C-terminal domain in the cytoplasmic sequestration of the p53 protein. J Biol Chem 273, 19817-19821.
32. Litchfield, D. W. (2003). Protein kinase CK2: structure, regulation and role in cellular decisions of life and death. Biochem J 369, 1-15.
33. MacPherson, D., Kim, J., Kim, T., Rhee, B. K., van Oostrom, C. T., DiTullio, R. A., Vanere, M., Halazonetis, T. D., Bronson, R. & other authors (2004). Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23. EMBO J 23, 3689-3699.
34. Mauser, A., Saito, S., Appella, E., Anderson, C. W., Seaman, W. T. & Kenney, S. (2002). The Epstein-Barr virus immediate-early protein BZLF1 regulates p53 function through multiple mechanisms. J Virol 76, 12503-12512.
35. Meek, D. W., Simon, S., Kikkawa, U. & Eckhart, W. (1990). The p53 tumour suppressor protein is phosphorylated at serine 389 by casein kinase II. EMBO J 9, 3253-3260.
36. Muralidhar, S., Doniger, J., Mendelson, E., Araujo, J. C., Kashanchi, F., Azumi, N., Brady, J. N. & Rosenthal, L. J. (1996). Human cytornegalovirus mtrII oncoprotein binds to p53 and down-regulates p53-activated transcription. J Virol 70, 8691-8700.
37. Naranatt, P. P., Akula, S. M., Zien, C. A., Krishnan, H. H. & Chandran, B. (2003). Kaposi's sarcoma -associ a ted herpesvirus induces the phospha-tidylinositol 3-kinase-PKC--MEK-ERK signaling pathway in target cells early during infection: implications for infectivity. J Virol 77, 1524-1539.
38. Øster, B. & Höllsberg, P. (2002). Viral gene expression patterns in human herpesvirus 6β-infected T cells. J Virol 76, 7578-7586.
39. Øster, B., Bundgaard, B. & Höllsberg, P. (2005). Human herpesvirus 6B induces cell cycle arrest concomitant with p53 phosphorylation and accumulation in T cells. J Virol 79, 1961-1965.
40. Øster, B., Kaspersen, M. D., Kofod-Olsen, E., Bundgaard, B. & Höllsberg, P. (2006). Human herpesvirus 6B inhibits cell proliferation by a p53-independent pathway. J Clin Virol 37, S63-S68.
41. Pan, H., Xie, J., Ye, F. & Gao, S. J. (2006). Modulation of Kaposi's sarcoma -associated herpesvirus infection and replication by MEK/ERK, JNK, and p38 multiple mitogen -activated protein kinase pathways during primary infection. J Virol 80, 5371-5382.
42. Pise-Masison, C. A., Radonovich, M., Sakaguchi, K., Appella, E. & Brady, J. N. (1998). Phosphorylation of p53: a novel pathway for p53 inactivation in human T-cell lymphotropic virus type 1-transformed cells. J Virol 72, 6348-6355.
43. Radhakrishnan, S. K. & Gartel, A. L. (2006). CDK9 phosphorylates p53 on serine residues 33, 315 and 392. Cell Cycle 5, 519-521.
44. Reed, L. J. & Muench, H. (1938). A simple method of estimating fifty per cent endpoints. Am J Hyg 27, 493-497.
45. Resnick, M. A., Tomso, D., Inga, A., Menendez, D. & Bell, D. (2005). Functional diversity in the gene network controlled by the master regulator p53 in humans. Cell Cycle 4, 1026-1029.
46. Sakaguchi, K., Sakamoto, H., Lewis, M. S., Anderson, C. W., Erickson, J. W., Appella, E. & Xie, D. (1997). Phosphorylation of serine 392 stabilizes the tetramer formation of tumor suppressor protein p53. Biochemistry 36, 10117-10124.
47. Seeber, S., Issinger, O. G., Holm, T., Kristensen, L. P. & Guerra, B. (2005). Validation of protein kinase CK2 as oncological target. Apoptosis 10, 875-885.
48. Shaulsky, G., Goldfinger, N., Ben-Ze'ev, A. & Rotter, V. (1990). Nuclear accumulation of p53 protein is mediated by several nuclear localization signals and plays a role in tumorigenesis. Mol Cell Biol 10, 6565-6577.
49. Shirata, N., Kudoh, A., Daikoku, T., Tatsumi, Y., Fujita, M., Kiyono, T., Sugaya, Y., Isomura, H., Ishizaki, K. & Tsurumi, T. (2005). Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection. J Biol Chem 280, 30336-30341.
50. Speir, E., Modali, R., Huang, E. S., Leon, M. B., Shawl, F., Finkel, T. & Epstein, S. E. (1994). Potential role of human cytomegalovirus and p53 interaction in coronary restenosis. Science 265, 391-394.
51. Takaoka, A., Hayakawa, S., Yanai, H., Stoiber, D., Negishi, H., Kikuchi, H., Sasaki, S., Imai, K., Shibue, T. & other authors (2003). Integration of interferon-α/β signalling to p53 responses in tumour suppression and antiviral defence. Nature 424, 516-523.
52. Takemoto, M., Mori, Y., Ueda, K., Kondo, K. & Yamanishi, K. (2004). Productive human herpesvirus 6 infection causes aberrant accumulation of p53 and prevents apoptosis. J Gen Virol 85, 869-879.
53. Takemoto, M., Koike, M., Mori, Y., Yonemoto, S., Sasamoto, Y., Kondo, K., Uchiyama, Y. & Yamanishi, K. (2005). Human herpesvirus 6 open reading frame U14 protein and cellular p53 interact with each other and are contained in the virion. J Virol 79, 13037-13046.
54. Tsai, H. L., Kou, G. H., Chen, S. C., Wu, C. W. & Lin, Y. S. (1996). Human cytomegalovirus immediate-early protein IE2 tethers a transcriptional repression domain to p53. J Biol Chem 271, 3534-3540.
55. Xie, J., Pan, H., Yoo, S. & Gao, S. J. (2005). Kaposi's sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen -activated protein kinase pathways. J Virol 79, 15027-15037.